Cellular and Molecular Life Sciences,
Год журнала:
2024,
Номер
81(1)
Опубликована: Янв. 12, 2024
Abstract
This
review
provides
an
update
on
recent
findings
from
basic,
translational,
and
clinical
studies
the
molecular
mechanisms
of
mitochondrial
dysfunction
apoptosis
hepatocytes
in
multiple
liver
diseases,
including
but
not
limited
to
alcohol-associated
disease
(ALD),
metabolic
dysfunction-associated
steatotic
(MASLD),
drug-induced
injury
(DILI).
While
ethanol-inducible
cytochrome
P450-2E1
(CYP2E1)
is
mainly
responsible
for
oxidizing
binge
alcohol
via
microsomal
ethanol
system,
it
also
metabolizing
many
xenobiotics,
pollutants,
chemicals,
drugs,
specific
diets
abundant
n-6
fatty
acids,
into
toxic
metabolites
organs,
liver,
causing
pathological
insults
through
organelles
such
as
mitochondria
endoplasmic
reticula.
Oxidative
imbalances
(oxidative
stress)
promote
covalent
modifications
lipids,
proteins,
nucleic
acids
enzymatic
non-enzymatic
mechanisms.
Excessive
changes
stimulate
various
post-translational
(PTMs)
transcription
factors,
histones.
Increased
PTMs
proteins
inactivate
enzymes
involved
reduction
oxidative
species,
acid
metabolism,
mitophagy
pathways,
leading
dysfunction,
energy
depletion,
apoptosis.
Unique
other
organelles,
control
signaling
cascades
bioenergetics
(fat
metabolism),
inflammation,
apoptosis/necrosis
hepatocytes.
When
homeostasis
shifted,
these
pathways
become
altered
or
shut
down,
likely
contributing
death
with
activation
inflammation
hepatic
stellate
cells,
fibrosis
cirrhosis.
will
encapsulate
how
contributes
hepatocyte
several
types
diseases
order
provide
recommendations
targeted
therapeutics.
Journal of Clinical and Translational Hepatology,
Год журнала:
2022,
Номер
10(5), С. 939 - 946
Опубликована: Июль 6, 2022
The
pathogenesis
of
metabolic-associated
fatty
liver
disease
(MAFLD)
is
complex
and
thought
to
be
dependent
on
multiple
parallel
hits
a
background
genetic
susceptibility.
evidence
suggests
that
MAFLD
progression
dynamic
two-way
process
relating
repetitive
bouts
metabolic
stress
inflammation
interspersed
with
endogenous
anti-inflammatory
reparative
responses.
In
MAFLD,
excessive
hepatic
lipid
accumulation
causes
the
production
lipotoxins
induce
mitochondrial
dysfunction,
endoplasmic
reticular
stress,
over
reactive
oxygen
species
(ROS).
Models
show
marked
disruption
function
reduced
oxidative
capacitance
impact
cellular
processes
including
mitophagy,
phosphorylation,
biogenesis.
excess,
ROS
modify
insulin
innate
immune
signaling
alter
expression
activity
essential
enzymes
involved
in
homeostasis.
can
also
cause
direct
damage
intracellular
structures
causing
hepatocyte
injury
death.
select
cases,
use
anti-oxidants
scavengers
have
been
shown
diminish
pro-apoptopic
effects
acids.
Given
this
link,
anti-oxidant
pathways
target
interest,
Nrf2
activation
showing
reduction
models
MAFLD.
Thyroid
hormone
receptor
β
(THRβ)
agonists
nuclear
peroxisome
proliferation-activated
(PPAR)
family
gained
interest
reducing
lipotoxicity
restoring
Unfortunately,
true
interplay
between
clinical
molecular
components
remain
only
partly
understood.
Most
recently,
multiomics-based
strategies
are
being
adopted
for
hypothesis-free
analysis
changes
Transcriptome
profiling
maps
unique
genotype-phenotype
associations
various
single-cell
transcriptome-based
projects
underway,
there
hope
novel
physiological
insights
uncover
therapeutic
targets.
Biomedicine & Pharmacotherapy,
Год журнала:
2022,
Номер
153, С. 113374 - 113374
Опубликована: Июль 11, 2022
Non-alcoholic
fatty
liver
disease
(NAFLD)
is
a
public
health
problem
associated
with
high
mortality
and
morbidity
rates
worldwide.
Presently,
its
complex
pathophysiology
still
unclear,
there
no
specific
drug
to
reverse
NAFLD.
Ferroptosis
an
iron-dependent
non-apoptotic
form
of
cell
death
characterized
by
the
iron-induced
accumulation
lipid
reactive
oxygen
species
(ROS),
which
damage
nucleic
acids,
proteins,
lipids;
generate
intracellular
oxidative
stress;
ultimately
cause
death.
Emerging
evidence
indicates
that
ferroptosis
involved
in
progression
NAFLD,
although
mechanism
action
NAFLD
poorly
understood.
Herein,
we
summarize
certain
diseases,
especially
pathogenesis
discuss
potential
therapeutic
approaches
currently
used
treat
This
review
also
highlights
further
directions
for
treatment
prevention
related
diseases.
Journal of Hepatology,
Год журнала:
2023,
Номер
79(2), С. 538 - 551
Опубликована: Март 7, 2023
The
liver
is
the
central
metabolic
organ
of
body,
regulating
energy
and
lipid
metabolism,
while
also
having
potent
immunological
functions.
Overwhelming
capacity
via
obesity
a
sedentary
lifestyle
leads
to
hepatic
accumulation,
chronic
necro-inflammation,
enhanced
mitochondrial/endoplasmic
reticulum
stress
development
non-alcoholic
fatty
disease
(NAFLD),
its
more
severe
form
steatohepatitis
(NASH).
Based
on
an
improved
understanding
pathophysiological
mechanisms,
specifically
targeting
pathways
prevent
or
slow
down
progression
NAFLD
cancer
will
become
possible.
Genetic/environmental
factors
are
known
contribute
NASH
cancer.
complex
pathophysiology
NAFLD-NASH
reflected
by
environmental
factors,
particularly
gut
microbiome
products.
NAFLD-associated
HCC
most
often
occurs
in
context
chronically
inflamed
cirrhotic
liver.
Recognition
alarmins
metabolites
derived
from
microbiota
metabolically
injured
create
strong
inflammatory
milieu
supported
innate
adaptive
immunity.
Several
recent
studies
indicate
that
steatosis
induces
auto-aggressive
CD8+CXCR6+PD1+
T
cells
eliminate
parenchymal
non-parenchymal
antigen-independent
manner.
This
promotes
damage
pro-tumorigenic
environment.
possess
exhausted,
hyperactivated,
resident
phenotype;
they
trigger
transition
might
be
responsible
for
weaker
responses
immune
checkpoint
inhibitors
-
particular
atezolizumab/bevacizumab.
Here,
we
provide
overview
NASH-related
inflammation/pathogenesis,
focusing
new
discoveries
role
cells.
review
discusses
preventive
measures
halt
therapeutic
strategies
manage
patients
with
NASH-HCC.
Smart Materials in Medicine,
Год журнала:
2023,
Номер
4, С. 427 - 446
Опубликована: Янв. 1, 2023
Reactive
oxygen
species
(ROS),
acting
as
essential
mediators
in
the
biological
system,
highly
influence
physiologic
and
pathologic
processes
of
human
body.
The
aberrant
production
ROS,
caused
by
various
diseases,
may
lead
to
inflammation
cellular
damages,
well
homeostasis
disruption.
In
recent
years,
biomaterials
sensitive
stimuli
have
received
increasing
attention
due
their
potential
for
achieving
more
specific
diagnoses
effective
treatments.
Particularly,
ROS-responsive
could
be
triggered
ROS
damaged
tissue
microenvironment
release
payloads
or
exert
a
therapeutically
beneficial
effect,
consequently
regulating
elevated
level
downregulating
oxidative
stress
promote
regeneration.
this
review,
we
outline
underlying
mechanisms
generation
diseases
summarize
cutting-edge
advances
developing
expedite
inflammation-related
regenerative
medicine
engineering
applications
body
systems.
particular,
pointed
out
challenges
shortcomings
that
current
ROS-sensitive
materials
encounter,
offer
distinctive
insights
into
field
present
solutions
improved
strategies.
Cellular and Molecular Life Sciences,
Год журнала:
2024,
Номер
81(1)
Опубликована: Янв. 12, 2024
Abstract
This
review
provides
an
update
on
recent
findings
from
basic,
translational,
and
clinical
studies
the
molecular
mechanisms
of
mitochondrial
dysfunction
apoptosis
hepatocytes
in
multiple
liver
diseases,
including
but
not
limited
to
alcohol-associated
disease
(ALD),
metabolic
dysfunction-associated
steatotic
(MASLD),
drug-induced
injury
(DILI).
While
ethanol-inducible
cytochrome
P450-2E1
(CYP2E1)
is
mainly
responsible
for
oxidizing
binge
alcohol
via
microsomal
ethanol
system,
it
also
metabolizing
many
xenobiotics,
pollutants,
chemicals,
drugs,
specific
diets
abundant
n-6
fatty
acids,
into
toxic
metabolites
organs,
liver,
causing
pathological
insults
through
organelles
such
as
mitochondria
endoplasmic
reticula.
Oxidative
imbalances
(oxidative
stress)
promote
covalent
modifications
lipids,
proteins,
nucleic
acids
enzymatic
non-enzymatic
mechanisms.
Excessive
changes
stimulate
various
post-translational
(PTMs)
transcription
factors,
histones.
Increased
PTMs
proteins
inactivate
enzymes
involved
reduction
oxidative
species,
acid
metabolism,
mitophagy
pathways,
leading
dysfunction,
energy
depletion,
apoptosis.
Unique
other
organelles,
control
signaling
cascades
bioenergetics
(fat
metabolism),
inflammation,
apoptosis/necrosis
hepatocytes.
When
homeostasis
shifted,
these
pathways
become
altered
or
shut
down,
likely
contributing
death
with
activation
inflammation
hepatic
stellate
cells,
fibrosis
cirrhosis.
will
encapsulate
how
contributes
hepatocyte
several
types
diseases
order
provide
recommendations
targeted
therapeutics.